Pasithea Therapeutics Cor... (KTTA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.42
-0.07 (-2.81%)
At close: Jan 15, 2025, 3:28 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | n/a | 486.56K | 15.06K | n/a |
Cost of Revenue | 648.45K | 113.19K | 17.27K | n/a |
Gross Profit | -648.45K | 373.36K | -2.21K | n/a |
Operating Income | -15.98M | -14.82M | -4.51M | -40.98K |
Interest Income | n/a | 102.00 | 508.00 | n/a |
Pretax Income | -15.51M | -13.94M | -2.17M | -40.98K |
Net Income | -15.96M | -13.06M | -2.17M | -40.98K |
Selling & General & Admin | 7.88M | 12.52M | 4.51M | 40.98K |
Research & Development | 8.10M | 2.67M | n/a | n/a |
Other Expenses | n/a | 44.72K | n/a | n/a |
Operating Expenses | 15.98M | 15.19M | 4.51M | 40.98K |
Interest Expense | n/a | 102.00 | 508.00 | n/a |
Selling & Marketing Expenses | -7.87B | 2.60M | n/a | n/a |
Cost & Expenses | 15.98M | 15.30M | 4.52M | 40.98K |
Income Tax | n/a | -879.97K | 508.00 | -61.48K |
Shares Outstanding (Basic) | 1.26M | 1.26M | 1.15M | 688.92K |
Shares Outstanding (Diluted) | 1.23M | 1.26M | 1.15M | 688.92K |
EPS (Basic) | -12.65 | -10.34 | -1.89 | -0.06 |
EPS (Diluted) | -13.01 | -10.34 | -1.89 | -0.06 |
EBITDA | -15.33M | -12.58M | -4.51M | n/a |
Depreciation & Amortization | 648.45K | 5.09K | 1.38K | 61.48K |